Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by ChupacabraBuenoon May 20, 2015 9:25am
187 Views
Post# 23744042

RE:RE:RE:RE:RE:RE:It's not about Tweed vs. Bedrocan Vs. Mettrum vs. also rans-

RE:RE:RE:RE:RE:RE:It's not about Tweed vs. Bedrocan Vs. Mettrum vs. also rans-I think you're right to be concerned by their expense levels. Sales of less than 1.5M$ is a greater concern IMO - but if they could sell something close to 7500Kg, or 60M$ in revenue, they would be in great shape. Current market cap is less than 100M$ - it could double or even triple with 60M$ revenue & over 20M$ gross profit. My concern is that sales at that level could be very hard to achieve while the injunction keeps the market oversupplied. -GLTA
Bullboard Posts